SCHEMBL5344739

SCHEMBL5344739

Cc1nc2nc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3)n2cc1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.43
CNR1 P21554 3/20 0.42
NPC1 O15118 5/20 0.40
RAB9A P51151 5/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
KDM4E B2RXH2 3/20 0.40
POLB P06746 1/20 0.40
DHODH Q02127 5/20 0.39
MAPT P10636 2/20 0.39
AHR P35869 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 2/20 0.38
DPP4 P27487 2/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38
ALDH1A1 P00352 1/20 0.38
DPP8 Q6V1X1 1/20 0.38
DPP9 Q86TI2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5322122 0.86 CNR1 (0.41) PTGS2CNR1NPC1RAB9ASMN1; SMN2
SCHEMBL5345503 0.84 HSD17B10 (0.47) NPC1RAB9ASMN1; SMN2KDM4EPOLB
SCHEMBL5318690 0.83 CNR1 (0.58) CNR1NPC1RAB9ASMN1; SMN2POLB
SCHEMBL5337361 0.83 CNR1 (0.60) CNR1NPC1RAB9ASMN1; SMN2POLB
SCHEMBL5350264 0.83 CNR1 (0.60) CNR1NPC1RAB9ASMN1; SMN2POLB
SCHEMBL5323774 0.81 CNR1 (0.43) PTGS2CNR1NPC1RAB9ASMN1; SMN2
SCHEMBL5355542 0.79 CNR1 (0.59) CNR1KDM4EALDH1A1TP53HPGD
SCHEMBL5340360 0.74 AKT1 (0.46) PTGS2NPC1RAB9ASMN1; SMN2POLB
SCHEMBL5337928 0.71 AKT1 (0.52) KDM4EDHODHHSD17B10
SCHEMBL5322344 0.71 AKT1 (0.55) PTGS2CNR1RAB9ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007096764-A2 BICYCLIC HETEROARYL DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS GLENMARK PHARMACEUTICALS S.A. (US) 2007-08-30 WO disclosed